Literature DB >> 11159019

GM-CSF regulates protein and lipid catabolism by alveolar macrophages.

M Yoshida1, M Ikegami, J A Reed, Z C Chroneos, J A Whitsett.   

Abstract

Metabolism of surfactant protein (SP) A and dipalmitoylphosphatidylcholine (DPPC) was assessed in alveolar macrophages isolated from granulocyte-macrophage colony-stimulated factor (GM-CSF) gene-targeted [GM(-/-)] mice, wild-type mice, and GM(-/-) mice expressing GM-CSF under control of the SP-C promoter element (SP-C-GM). Although binding and uptake of (125)I-SP-A were significantly increased in alveolar macrophages from GM(-/-) compared with wild type or SP-C-GM mice, catabolism of (125)I-SP-A was markedly decreased in GM(-/-) mice. Association of [(3)H]DPPC with alveolar macrophages from GM(-/-), wild-type, and SP-C-GM mice was similar; however, catabolism of DPPC was markedly reduced in cells from GM(-/-) mice. Fluorescence-activated cell sorter analysis demonstrated decreased catabolism of rhodamine-labeled dipalmitoylphosphatidylethanolamine by alveolar macrophages from GM(-/-) mice. GM-CSF deficiency was associated with increased SP-A uptake by alveolar macrophages but with impaired surfactant lipid and SP-A degradation. These findings demonstrate the important role of GM-CSF in the regulation of alveolar macrophage lipid and SP-A catabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159019     DOI: 10.1152/ajplung.2001.280.3.L379

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  39 in total

Review 1.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

2.  GM-CSF action in the CNS decreases food intake and body weight.

Authors:  Jacquelyn A Reed; Deborah J Clegg; Kathleen Blake Smith; Emeline G Tolod-Richer; Emily K Matter; Lara S Picard; Randy J Seeley
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

3.  The involvement of GM-CSF deficiencies in parallel pathways of pulmonary alveolar proteinosis and the alcoholic lung.

Authors:  William S Slovinsky; Freddy Romero; Dominic Sales; Hoora Shaghaghi; Ross Summer
Journal:  Alcohol       Date:  2018-07-18       Impact factor: 2.405

4.  Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.

Authors:  Hazem E Ghoneim; Paul G Thomas; Jonathan A McCullers
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

5.  Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.

Authors:  Andrew Ferretti; Jarrod R Fortwendel; Sarah A Gebb; Robert A Barrington
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

6.  Stat5 Is Required for CD103+ Dendritic Cell and Alveolar Macrophage Development and Protection from Lung Injury.

Authors:  William E Eddy; Ke-Qin Gong; Bryan Bell; William C Parks; Steven F Ziegler; Anne M Manicone
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

7.  Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.

Authors:  Takuji Suzuki; Takuro Sakagami; Lisa R Young; Brenna C Carey; Robert E Wood; Maurizio Luisetti; Susan E Wert; Bruce K Rubin; Katharine Kevill; Claudia Chalk; Jeffrey A Whitsett; Carrie Stevens; Lawrence M Nogee; Ilaria Campo; Bruce C Trapnell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 8.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

9.  Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages.

Authors:  R Subramaniam; S Mukherjee; H Chen; S Keshava; P Neuenschwander; H Shams
Journal:  Mucosal Immunol       Date:  2015-11-18       Impact factor: 7.313

10.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.